The Royal College of Physicians Report on E-cigarette Use

Regulations by 2FIRSTS.ai
Apr.24.2024
The Royal College of Physicians Report on E-cigarette Use
In a new report, the Royal College of Physicians suggests that e-cigarettes are effective for quitting smoking but need regulation.

According to a report released by the Royal College of Physicians (RCP) on April 23, e-cigarettes are an effective aid for quitting smoking. However, more measures should be taken to reduce the appeal, availability, and affordability of e-cigarettes to non-smokers, as well as minimize their impact on the environment.

 

The results were summarized into over 50 recommendations, which explored trends in the use of combustible tobacco and e-cigarette products, differences in the health impacts of e-cigarettes on smokers, non-smokers, or both, as well as environmental damage, and the role of e-cigarette use in the expansion of the tobacco industry.

 

The conclusion of the RCP report is that since the 2016 RCP report, the evidence of the effectiveness of e-cigarette-assisted smoking cessation has become stronger. In recent years, there has been a significant increase in the number of young people and non-smokers using e-cigarettes, so timely remedial measures are needed to curb youth e-cigarette use while not affecting the use of e-cigarettes as a smoking cessation aid for adults. The government should commission regular updates on the evidence of the use and impact of nicotine products to guide policies.

 

Researchers emphasize that e-cigarettes should be promoted as an effective tool to help smokers quit smoking, particularly focusing on those who stand to benefit the most, such as individuals with mental health disorders or those in socioeconomically disadvantaged positions, or living in social housing.

 

Researchers reviewed the potential adverse effects of using e-cigarette products on health by examining biomarkers of e-cigarette exposure and harm from data released between 2021 and 2023. They compared e-cigarette users, smokers, dual users (both using e-cigarettes and smoking), and non-users of both products.

 

Although harmful substance levels of e-cigarette users are found to be lower than smokers in many biomarker analyses, researchers have concluded the need for consensus on methods for studying the health risks of e-cigarettes. This includes determining which biomarkers are most relevant in relative and absolute studies. Larger sample studies are necessary for both e-cigarette users with a history of smoking and those who have never smoked in order to reach accurate conclusions.

 

When it comes to teenage addiction issues, researchers at the RCP have concluded that standardized plain packaging should be introduced, flavors and brand descriptions should be reduced, and retail display bans should be implemented to decrease teenagers' interest in trying e-cigarettes. Price and tax strategies for e-cigarettes should make the most commonly used and cheapest product by teenage e-cigarette users (disposable e-cigarettes) less affordable, while ensuring that products most likely to be used by adults who smoke or are trying to quit (rechargeable and refillable e-cigarettes) have minimal environmental impact and remain affordable.

 

The report also suggests increasing prices by imposing a consumption tax and setting minimum prices, prohibiting multiple purchases, but ensuring that they remain a more affordable option for adults who use them to quit smoking. It also recommends limiting the visibility of promotional materials in retail stores and products, as well as restricting promotional activities on social media. At the same time, the report authors are urging regulatory agencies to prevent cigarette manufacturers from influencing national policy-making.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
British American Tobacco (BAT) has announced plans to cut 51 jobs at its Groot-Bijgaarden facility in Belgium, disclosed during a special works council meeting.
Jan.15 by 2FIRSTS.ai
JT launches limited-edition Ploom AURA front panels; two go on sale, three offered via prize draw
JT launches limited-edition Ploom AURA front panels; two go on sale, three offered via prize draw
Japan Tobacco (JT) has rolled out an Ichiro Yamaguchi collaboration under its Ploom AURA “SENSATIONAL” campaign, using a combined marketing push—limited sales, a prize draw, video content distribution and in-store displays—to release five front panels and two branded accessories. Two panels will go on sale from Jan. 27, while the remaining panels and accessories will be distributed through a draw running from Jan. 19 to Feb. 28.
Jan.19 by 2FIRSTS.ai
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Alimentation Couche-Tard reported that nicotine products accounted for 9% of total revenue in fiscal 2025, making it the company’s second-largest revenue source after fuel, according to its latest Business Strategy Update.
Market
Feb.19
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia’s Chamber of Commerce and Industry and the Tax and Customs Board are urging the government to address a thriving illicit vape market that undermines fair competition and makes vapes easily accessible to minors.
Feb.04 by 2FIRSTS.ai
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China’s Ministry of Finance and State Taxation Administration have announced adjustments to export tax rebate policies, placing nicotine-containing non-combustible inhalation products within the scope of items subject to rebate cancellation. The measures will take effect from April 1, 2026.
Regulations
Jan.10